BioNeutra Global (TSXV:BGA) Change In Receivables : C$-0.03 Mil (TTM As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global Change In Receivables?

BioNeutra Global's change in receivables for the quarter that ended in Mar. 2024 was C$0.22 Mil. It means BioNeutra Global's Accounts Receivable declined by C$0.22 Mil from Dec. 2023 to Mar. 2024 .

BioNeutra Global's change in receivables for the fiscal year that ended in Dec. 2023 was C$-0.12 Mil. It means BioNeutra Global's Accounts Receivable increased by C$0.12 Mil from Dec. 2022 to Dec. 2023 .

BioNeutra Global's Accounts Receivable for the quarter that ended in Mar. 2024 was C$0.94 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. BioNeutra Global's Days Sales Outstanding for the three months ended in Mar. 2024 was 34.97.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. BioNeutra Global's liquidation value for the three months ended in Mar. 2024 was C$-19.20 Mil.

BioNeutra Global Change In Receivables Historical Data

The historical data trend for BioNeutra Global's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global Change In Receivables Chart

BioNeutra Global Annual Data

Trend

Feb14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

1.25

1.66

-0.09

0.63

-0.12

BioNeutra Global Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															0.12	-0.32	0.26	-0.18	0.22

BioNeutra Global Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.03 Mil.

BioNeutra Global (TSXV:BGA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

BioNeutra Global's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.942	/	2.458	*	91
=	34.97

2. In Ben Graham's calculation of liquidation value, BioNeutra Global's accounts receivable are only considered to be worth 75% of book value:

BioNeutra Global's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.47	-	22.648	+	0.75 * 0.942	+	0.5 * 4.538
=	-19.20

BioNeutra Global Change In Receivables Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNeutra Global (TSXV:BGA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

BGACF:USA

Address

9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4

Website

http://www.bioneutra.ca

BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.

Executives

Monica Barclay

Senior Officer

BioNeutra Global (TSXV:BGA) Headlines

No Headlines